Core Viewpoint - Enwei Pharmaceutical Co., Ltd. has announced its 2025 interim dividend distribution plan, which includes a cash dividend of RMB 3.50 per 10 shares for shareholders, based on a total share capital of 101,836,561 shares after excluding repurchased shares [2][4]. Group 1: Dividend Distribution Plan - The company will distribute a cash dividend of RMB 3.50 per 10 shares (including tax), amounting to a total cash dividend of RMB 35,642,796.35 [2][4]. - The dividend distribution is based on the total share capital of 102,891,887 shares, minus the repurchased shares of 1,055,326, resulting in a distribution base of 101,836,561 shares [2][4]. - The cash dividend per share, calculated based on the total share capital, is approximately RMB 0.3464101 [14]. Group 2: Shareholder Meeting and Approval - On May 12, 2025, the company's annual shareholder meeting approved the proposal to authorize the board to formulate and implement the 2025 interim profit distribution plan [3]. - The board of directors approved the interim dividend plan on December 26, 2025, confirming the distribution method and amount [4][5]. Group 3: Key Dates - The record date for the dividend distribution is set for January 7, 2026, and the ex-dividend date is January 8, 2026 [8][9]. Group 4: Dividend Payment Method - The cash dividends will be directly credited to the shareholders' accounts through the securities custody company on the ex-dividend date [11]. - The company will bear all legal responsibilities if there are any discrepancies in the dividend distribution due to changes in shareholders' accounts during the application period [12].
恩威医药股份有限公司2025年中期分红派息实施公告